title: Weekly 24-hour infusion of high-dose 5-fluorouracil plus folinic acid in combination with mitomycin C for the treatment of advanced gastric cancer.
abstract: OBJECTIVE
  This study was performed to investigate the activity and safety of high dose 5-fluorouracil (5-FU) given as a weekly 24-hour infusion in combination with folinic acid plus mitomycin C in patients with advanced gastric cancer.
  
  
  METHODS
  Chemonaive patients with locally advanced inoperable, recurrent or metastatic gastric cancer were treated with 15 mg/m(2) i.v. mitomycin C as bolus on day 1 of a 7-week cycle followed by a 2-hour infusion of folinic acid (500 mg/m(2)) and a 24-hour infusion of 5-FU (2,600 mg/m(2)) given on days 1, 8, 15, 22, 29, and 36 as outpatient treatment.
  
  
  RESULTS
  Thirty evaluable patients (median age 58 years and median ECOG performance status 1) received 1-4 cycles (median 3). 53% of the patients had liver metastases. Treatment-related toxicity was low with 10% of patients experiencing diarrhea >/=grade 3, 3% mucositis grade 3 and 3% nausea grade 3 (CTC). Hematological toxicity was mild with 13% thrombopenia grade 3 and no leukopenia grade 4. Eleven patients achieved a partial remission (major response rate 37%; 95% confidence interval 22-53%). Median time to progression was 5 months and median overall survival time was 7 months.
  
  
  CONCLUSIONS
  This regimen is a well-tolerated outpatient treatment for patients with advanced gastric cancer with efficacy being comparable to other chemotherapy protocols.
authors.affiliation: Department of Internal Medicine, Hematology, Oncology and Tumorimmunology, Robert Rössle Hospital, Charité, Campus Buch, Humboldt University of Berlin, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Kretzschmar
authors.forename: P
authors.initials: P
authors.lastname: Reichardt
authors.forename: P C
authors.initials: PC
authors.lastname: Thuss-Patience
authors.forename: P
authors.initials: P
authors.lastname: Hohenberger
authors.forename: T
authors.initials: T
authors.lastname: Benter
authors.forename: B
authors.initials: B
authors.lastname: Dörken
authors.forename: C H
authors.initials: CH
authors.lastname: Köhne
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage; D009362:Neoplasm Metastasis; D013274:Stomach Neoplasms / Q000188:drug therapy*
chemical_list: D016685:Mitomycin; D002955:Leucovorin; D005472:Fluorouracil